Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04594109 · ClinicalTrials.gov registry record · NA
Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04594109: Completed NA study, sponsored by Colorado State University.
NCT04594109 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04594109, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. The investigators conducted a pilot randomized controlled trial (RCT) to evaluate a tailored smoking cessation intervention based on the minority stress model, hypothesizing that behavioral counseling through this lens would enhance cessation. The investigators compared standard of care counseling (SOC) to a tailored intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy to build resilience, and 30 days of 2-way text messaging.
Primary Outcome
7-day point prevalence plus exhaled breath carbon monoxide \< 7 parts per million (ppm)
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Tailored behavioral counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-06-30 |
| Est. Completion | 2018-01-30 |
| Phase | NA |
What the finished NCT04594109 record still lists
NCT04594109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04594109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04594109 about?
NCT04594109 is a clinical study titled "Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.". Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. The investigators conducted a pilot randomized controlled trial (RCT) to...
What is the current status of trial NCT04594109?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-06-30. Estimated completion is 2018-01-30.
What interventions are being tested in trial NCT04594109?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Tailored behavioral counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04594109?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04594109's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI